Deep Track Capital LP 13D and 13G filings for MoonLake Immunotherapeutics:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-12 4:02 pm Purchase | 2025-11-05 | 13G | MoonLake Immunotherapeutics MLTX | Deep Track Capital LP | 4,610,071 6.460% | 4,610,071 (New Position) | Filing |